Fisher Wallace Laboratories on StartEngine

Medical Devices for Mood and Sleep

Key Stats

Minimum Raise


Maximum Raise


Likelihood of Max Extremely
Start Date


Stop Date


Days Remaining


Security Type


Investment Minimum


Deal Type

No Review

Kingscrowd Momentum


Total Dollars Raised

SEC Filing Data from Kingscrowd

Fisher Wallace Laboratories, with a pre-money valuation of $15 million, is raising funds on StartEngine. The company is developing an FDA-cleared, clinically validated, wearable treatment for insomnia, anxiety, and depression. The Fisher Wallace Stimulator stimulates the brain to produce more serotonin and other neurochemicals, and less cortisol. The device has shown to have 75% effectiveness and only 1% side effects in clinical trials and practice. Fisher Wallace Laboratories was founded by Kelly Roman and Charles Fisher in 2007. The proceeds of the current crowdfunding round, with a minimum goal of $10,000 and a maximum goal of $1,070,000, will be used to continue the development of Version 2 device and to grow the sales of Version 1. Fisher Wallace Laboratories already has lifetime revenues of $23.3 million, with $4.7 million of net revenue in 2018.